PredxBio, Inc.
PrivateLast Round
Series A
Feb 14, 2023
Est. Valuation
$12M
Total Funding Raised
$4.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PredxBio, Inc. operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Series A round in February 2023.
PredxBio, Inc. is a health technology company that provides a decision-intelligence platform for drug discovery and clinical development by analyzing spatial multi-omic data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PredxBio, Inc. Comparables
Compare PredxBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 84% | |
| Voyant Bio | 81% | |
| Perception Medicine | 77% |
For institutional investors. Book with your work email.
PredxBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 14, 2023 | ||||
| Accelerator | Jan 1, 2021 | ||||
| VC Round | Aug 6, 2019 | ||||
| Grant | Mar 1, 2019 | ||||
| Seed | Sep 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PredxBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab Health | Accelerator |
| Keiretsu Forum | Series A |
| AHN | Accelerator |
| Innovation Works | Series A, Accelerator |
| Newlin Investment Company | Series A, Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 159% MoM, reaching 9.3K.
- Jul 24, 2026
Monthly visitors increased 245% MoM.
For institutional investors. Book with your work email.
PredxBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PredxBio, Inc.'s valuation, stock price, and market status.
Is PredxBio, Inc. a public or private company?
PredxBio, Inc. is a private company.
What is the current stock price of PredxBio, Inc.?
PredxBio, Inc. is a private company, so its shares have no public market price. Caplight tracks PredxBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PredxBio, Inc. worth (valuation)?
PredxBio, Inc.'s valuation is estimated at $12.0M based on funding round data.
Can I buy PredxBio, Inc. stock?
PredxBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PredxBio, Inc.'s last funding round?
PredxBio, Inc.'s most recent funding round was Series A on February 14, 2023.
Who are the main investors in PredxBio, Inc.?
Key investors in PredxBio, Inc. include AlphaLab Health, Newlin Investment Company.
Will PredxBio, Inc. IPO soon?
No public IPO plans have been announced for PredxBio, Inc..
How can I track PredxBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PredxBio, Inc.'s shares on secondary markets.